MEVITEM - A Phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
暂无分享，去创建一个
D. Frappaz | O. Chinot | A. Hottinger | G. Garin | D. Pérol | F. Laigle-Donadey | É. Le Rhun | D. Meyronet | M. Barritault | A. Bonneville-Levard | A. Bidaux | L. Montané